Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,417 | 323 | 98.8% |
| Long term medical supply or device loan | $49.95 | 1 | 0.9% |
| Education | $16.58 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $869.04 | 46 | $0 (2024) |
| Amgen Inc. | $706.81 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $561.54 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $367.01 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $326.51 | 21 | $0 (2024) |
| PFIZER INC. | $320.38 | 24 | $0 (2024) |
| Novo Nordisk Inc | $314.89 | 20 | $0 (2024) |
| Allergan Inc. | $179.77 | 10 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $164.93 | 10 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $158.66 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,306 | 64 | AstraZeneca Pharmaceuticals LP ($281.60) |
| 2023 | $1,032 | 57 | Amgen Inc. ($237.71) |
| 2022 | $690.90 | 41 | Amgen Inc. ($113.76) |
| 2021 | $617.78 | 37 | AstraZeneca Pharmaceuticals LP ($151.26) |
| 2020 | $142.22 | 9 | GlaxoSmithKline, LLC. ($52.30) |
| 2019 | $558.70 | 37 | GlaxoSmithKline, LLC. ($96.56) |
| 2018 | $565.71 | 39 | GlaxoSmithKline, LLC. ($90.20) |
| 2017 | $570.15 | 42 | GlaxoSmithKline, LLC. ($103.61) |
All Payment Transactions
326 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: PAIN | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Endocrinology | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: PAIN | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: VACCINES | ||||||
| 08/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: PAIN | ||||||
| 08/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: PAIN | ||||||
| 08/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Biological | ||||||
| 08/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Cardiology | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.37 | General |
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,074 | 2,048 | $394,627 | $99,325 |
| 2022 | 16 | 1,209 | 2,259 | $407,270 | $106,626 |
| 2021 | 18 | 1,290 | 2,304 | $388,078 | $110,467 |
| 2020 | 18 | 1,432 | 2,696 | $406,990 | $105,927 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 95 | 480 | $192,960 | $34,513 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 258 | 446 | $88,754 | $29,468 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 262 | $35,632 | $15,352 | 43.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $13,500 | $5,048 | 37.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 271 | 485 | $12,610 | $4,044 | 32.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 45 | 46 | $3,220 | $3,155 | 98.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 26 | 26 | $15,288 | $2,613 | 17.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 49 | $2,058 | $1,453 | 70.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 28 | 31 | $9,486 | $1,147 | 12.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 41 | 43 | $8,643 | $737.06 | 8.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $684.00 | $563.54 | 82.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 56 | $3,024 | $541.00 | 17.9% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 12 | 12 | $2,376 | $277.86 | 11.7% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 11 | $2,233 | $215.21 | 9.6% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 29 | 29 | $3,074 | $119.25 | 3.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 22 | 35 | $1,085 | $77.00 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 311 | 670 | $128,640 | $53,500 | 41.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 101 | 466 | $187,332 | $28,018 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 177 | $23,187 | $10,147 | 43.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 63 | 63 | $4,410 | $4,305 | 97.6% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Office | 2022 | 43 | 47 | $19,693 | $2,844 | 14.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 69 | 69 | $1,794 | $1,735 | 96.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 294 | 464 | $12,064 | $1,366 | 11.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,242 | $1,146 | 27.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 34 | 34 | $6,834 | $712.46 | 10.4% |
About Dr. Daniel Woods, MD
Dr. Daniel Woods, MD is a Family Medicine healthcare provider based in Savanna, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942276159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Woods, MD has received a total of $5,484 in payments from pharmaceutical and medical device companies, with $1,306 received in 2024. These payments were reported across 326 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,417).
As a Medicare-enrolled provider, Woods has provided services to 5,005 Medicare beneficiaries, totaling 9,307 services with total Medicare billing of $422,345. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Savanna, IL
- Active Since 02/27/2006
- Last Updated 10/26/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1942276159
Products in Payments
- Otezla (Drug) $517.36
- TRELEGY ELLIPTA (Drug) $350.86
- FARXIGA (Drug) $332.41
- XARELTO (Drug) $298.81
- ELIQUIS (Drug) $235.81
- AIRSUPRA (Drug) $189.79
- NURTEC ODT (Drug) $182.48
- Kerendia (Drug) $164.93
- Catalyst CSR Shoulder System (Device) $152.31
- VRAYLAR (Drug) $143.43
- Ozempic (Drug) $135.00
- JARDIANCE (Drug) $133.84
- ENTRESTO (Drug) $113.26
- BREO (Drug) $104.95
- TRADJENTA (Drug) $86.63
- Rybelsus (Drug) $86.44
- REXULTI (Drug) $84.42
- BRILINTA (Drug) $79.87
- ANORO (Drug) $78.22
- EVENITY (Biological) $77.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.